These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8625259

  • 21. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.
    Shridhar V, Sun QC, Miller OJ, Kalemkerian GP, Petros J, Smith DI.
    Oncogene; 1997 Nov 27; 15(22):2727-33. PubMed ID: 9400999
    [Abstract] [Full Text] [Related]

  • 22. Detection of deletions in the short arm of chromosome 3 in uncultured renal cell carcinomas by interphase cytogenetics.
    Siebert R, Jacobi C, Matthiesen P, Zühlke-Jenisch R, Potratz C, Zhang Y, Stöckle M, Klöppel G, Grote W, Schlegelberger B.
    J Urol; 1998 Aug 27; 160(2):534-9. PubMed ID: 9679924
    [Abstract] [Full Text] [Related]

  • 23. Frequent breakpoints in the region surrounding FRA3B in sporadic renal cell carcinomas.
    Shridhar V, Wang L, Rosati R, Paradee W, Shridhar R, Mullins C, Sakr W, Grignon D, Miller OJ, Sun QC, Petros J, Smith DI.
    Oncogene; 1997 Mar 20; 14(11):1269-77. PubMed ID: 9178887
    [Abstract] [Full Text] [Related]

  • 24. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
    Béroud C, Fournet JC, Jeanpierre C, Droz D, Bouvier R, Froger D, Chrétien Y, Maréchal JM, Weissenbach J, Junien C.
    Genes Chromosomes Cancer; 1996 Dec 20; 17(4):215-24. PubMed ID: 8946203
    [Abstract] [Full Text] [Related]

  • 25. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD, Bigler S, Dickman K, Kovacs G.
    Mod Pathol; 1999 Mar 20; 12(3):301-9. PubMed ID: 10102616
    [Abstract] [Full Text] [Related]

  • 26. Allelic loss on chromosomes 3p, 5q and 17p in renal cell carcinomas.
    Sugimura J, Tamura G, Suzuki Y, Fujioka T.
    Pathol Int; 1997 Mar 20; 47(2-3):79-83. PubMed ID: 9088024
    [Abstract] [Full Text] [Related]

  • 27. Cytogenetic findings in renal cell carcinoma.
    Iqbal MA, Akhtar M, Ali MA.
    Hum Pathol; 1996 Sep 20; 27(9):949-54. PubMed ID: 8816891
    [Abstract] [Full Text] [Related]

  • 28. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma.
    Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Müller-Brechlin R, Klein G, Sümegi J.
    Proc Natl Acad Sci U S A; 1988 Mar 20; 85(5):1571-5. PubMed ID: 2894030
    [Abstract] [Full Text] [Related]

  • 29. Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization.
    Salama ME, Worsham MJ, DePeralta-Venturina M.
    Arch Pathol Lab Med; 2003 Sep 20; 127(9):1176-81. PubMed ID: 12946227
    [Abstract] [Full Text] [Related]

  • 30. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C, Martinez A, Zatyka M, Agathanggelou A, Honorio S, Astuti D, Morgan NV, Moch H, Richards FM, Kishida T, Yao M, Schraml P, Latif F, Maher ER.
    Cancer Res; 2001 Oct 01; 61(19):7277-81. PubMed ID: 11585766
    [Abstract] [Full Text] [Related]

  • 31. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22.
    Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, Bentley E, Affara NA, Ferguson-Smith MA, Maher ER.
    Br J Cancer; 1994 Feb 01; 69(2):230-4. PubMed ID: 8297719
    [Abstract] [Full Text] [Related]

  • 32. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.
    Ogawa O, Kakehi Y, Ogawa K, Koshiba M, Sugiyama T, Yoshida O.
    Cancer Res; 1991 Feb 01; 51(3):949-53. PubMed ID: 1671000
    [Abstract] [Full Text] [Related]

  • 33. Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma.
    Schraml P, Müller D, Bednar R, Gasser T, Sauter G, Mihatsch MJ, Moch H.
    J Pathol; 2000 Mar 01; 190(4):457-61. PubMed ID: 10699995
    [Abstract] [Full Text] [Related]

  • 34. The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma.
    Wu SQ, Hafez GR, Xing W, Newton M, Chen XR, Messing E.
    Cancer; 1996 Mar 15; 77(6):1154-60. PubMed ID: 8635138
    [Abstract] [Full Text] [Related]

  • 35. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
    Lovell M, Lott ST, Wong P, El-Naggar A, Tucker S, Killary AM.
    Cancer Res; 1999 May 01; 59(9):2182-9. PubMed ID: 10232606
    [Abstract] [Full Text] [Related]

  • 36. Loss of heterozygosity on the short arm of chromosome 3 in renal cancer.
    Maestro ML, del Barco V, Sanz-Casla MT, Moreno J, Adrover E, Izquierdo L, Zanna I, Fernández C, Redondo E, Blanco J, Resel L.
    Oncology; 2000 Aug 01; 59(2):126-30. PubMed ID: 10971171
    [Abstract] [Full Text] [Related]

  • 37. Duplication of two distinct regions on chromosome 5q in non-papillary renal-cell carcinomas.
    Bugert P, Von Knobloch R, Kovacs G.
    Int J Cancer; 1998 May 04; 76(3):337-40. PubMed ID: 9579569
    [Abstract] [Full Text] [Related]

  • 38. Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction.
    Suzuki Y, Tamura G, Maesawa C, Fujioka T, Kubo T, Satodate R.
    Virchows Arch; 1994 May 04; 424(5):453-7. PubMed ID: 8032525
    [Abstract] [Full Text] [Related]

  • 39. Microsatellite analysis reveals deletion of a large region at chromosome 8p in conventional renal cell carcinoma.
    Schullerus D, von Knobloch R, Chudek J, Herbers J, Kovacs G.
    Int J Cancer; 1999 Jan 05; 80(1):22-4. PubMed ID: 9935224
    [Abstract] [Full Text] [Related]

  • 40. VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance.
    Velickovic M, Delahunt B, Störkel S, Grebem SK.
    Cancer Res; 2001 Jun 15; 61(12):4815-9. PubMed ID: 11406557
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.